StanCon2018 Asilomar CA
Channel: Stan
Date: 16/02/2018

Assessing the safety of Rosiglitazone for the treatment of type II diabetes. Konstantinos Vamvourellis, K. Kalogeropoulos, L. Phillips (London School of Economics and Political Science)